FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
GENEREX BIOTECHNOLOGY CORP [ GNBT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 03/08/2010 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Common Stock Purchase Option (right to buy) | $0.94 | 10/20/2009 | D(1) | 70,000 | (2) | 10/26/2009 | Common Stock | 70,000 | $0 | 0 | D | ||||
Common Stock Purchase Option (right to buy) | $0.94 | 10/20/2009 | A | 70,000 | (2) | 10/26/2014 | Common Stock | 70,000 | $0 | 70,000 | D | ||||
Common Stock Purchase Option (right to buy) | $0.001 | 10/20/2009 | D(1) | 35,714 | (3) | 04/04/2010 | Common Stock | 35,714 | $0 | 0 | D | ||||
Common Stock Purchase Option (right to buy) | $0.001 | 10/20/2009 | A | 35,714 | (3) | 10/26/2014 | Common Stock | 35,714 | $0 | 35,714 | D | ||||
Common Stock Purchase Option (right to buy) | $0.56 | 10/20/2009 | D(1) | 100,000 | (4) | 04/04/2010 | Common Stock | 100,000 | $0 | 0 | D | ||||
Common Stock Purchase Option (right to buy) | $0.56 | 10/20/2009 | A | 100,000 | (4) | 10/26/2014 | Common Stock | 100,000 | $0 | 100,000 | D | ||||
Common Stock Purchase Option (right to buy) | $0.64 | 03/08/2010 | A | 100,000 | (5) | 03/07/2020 | Common Stock | 100,000 | $0 | 100,000 | D |
Explanation of Responses: |
1. Deemed cancellation of option in connection with deemed grant of replacement option. |
2. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on October 26, 2004. The original terms of vesting were not amended. |
3. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended. |
4. The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended. |
5. This option becomes exercisable in three installments, with the first installment (33,333 shares) exercisable as of the date of grant, the second installment (33,3333 shares) exercisable as of August 1, 2010 and the third installment (33,334 shares) exercisable as of August 1, 2011. |
/s/ Brian McGee | 03/10/2010 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |